Tocilizumab in the Treatment of Refractory Polymyositis and Dermatomyositis

NCT02043548 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Dermatomyositis
Polymyositis

Interventions

DRUG: tocilizumab
DRUG: placebo

Sponsor

Chester Oddis

Collaborators

[object Object]